Ferimac Injection

Injection

IV

Each 5ml ampoule contains:

• Ferric Hydroxide in Complex with Sucrose eq. to elemental Iron 100 mg
• Water for Injections I.P. q.s.

Ferimac Injection is an aqueous complex of poly-nuclear iron (III)-hydroxide in sucrose. Following intravenous administration, it dissociates into iron and sucrose, and the iron is transported as a complex with transferrin to target cells including erythroid precursor cells. The iron in the precursor cells is incorporated into haemoglobin as the cells mature into red blood cells.

Ferimac Injection is indicated for the treatment of iron deficiency anemia (IDA) in patients with chronic kidney disease (CKD).

As directed by the physician.

The most common side effects: Headache, Respiratory tract viral infection, Peritonitis, Vomiting, Pyrexia, Dizziness, Cough, Nausea, Arteriovenous Fistula thrombosis, Hypotension, Hypertension.

Ferimac Injection is contraindicated in patients with known hypersensitivity to any of the ingredients.

Ferimac Injection may reduce the absorption of concomitantly administered oral iron preparations.

Store at controlled room temperature. Do not freeze.

18x10x1x5ml.